Jun Zhang, MD, PhD

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Jun Zhang, MD, PhD sits in the upper quartile of US sponsors by registered trial count (#3,661 of 15,742 sponsors by registered trial count).

3 total trials 2 currently recruiting early-phase tilt upper quartile by trial count

Jun Zhang, MD, PhD: 3 sponsored US clinical trials, 2 recruiting.

Jun Zhang, MD, PhD sponsors 3 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting. 0 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is NSCLC, Stage III, with 1 trials.

Upper-quartile sponsor footprint

Jun Zhang, MD, PhD sits in the upper quartile of the sponsor corpus (#3,661 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

Open and recent trials

3 total, page 1 of 1

RECRUITING

Using Ex Vivo Tumoroids To Predict Immunotherapy Response In NSCLC

NCT05332925
RECRUITING

Using Microbiome to Predict Durvalumab Toxicity in Post- Concurrent Chemoradiation Therapy (CCRT) NSCLC Patients

NCT04680377
NOT YET RECRUITING Phase 2

A Study of Combining Cabozantinib and Atezolizumab for Advanced/Metastatic NSCLC (Cabatezo-1)

NCT05859217

Phase Distribution

PhaseTrial count
Phase 2 1

Therapeutic Areas

NSCLC, Stage III 1
NSCLC Stage IV 1
Locally Advanced Lung Carcinoma 1
NSCLC 1
Lung Cancer 1

What is open in the Jun Zhang, MD, PhD pipeline

2 recruiting of 3 indexed (67% open).

Phase mix: 0 late (III/IV) vs 1 early (I/II) (early-phase heavy).

Top condition: NSCLC, Stage III (1 trial), 4 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Jun Zhang, MD, PhD: open-pipeline peers nationwide

Peers matched on 3 registered trials and 67% open enrollment, not the therapeutic-area sidebar.

Jun Zhang, MD, PhD sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 234567 0%20%40%60%80% Total trials Recruiting share Jun Zhang, MD, PhD10xBio22nd Century GroupAA SecordAAADRS Clinical Research CenterAbbisko Therapeutics CoABL BioAccelerated Cure Project for Multiple SclerosisAdvanced Reconstructive Surgery Alliance
Jun Zhang, MD, PhD sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Jun Zhang, MD, PhD sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 3 trials (± recruiting share)

Sponsors near 67% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Jun Zhang, MD, PhD page

3 registered trials is a research-attention snapshot, not an endorsement of Jun Zhang, MD, PhD or any single study.

  • 2 of Jun Zhang, MD, PhD's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • NSCLC, Stage III is the condition Jun Zhang, MD, PhD studies most, compare against other sponsors active in the same condition before evaluating a specific study. See NSCLC, Stage III trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Jun Zhang, MD, PhD pipeline card: 3 registered trials from official public datasets.Report a data error.